The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Share News (FEVR)

Share Price Information for Fevertree (FEVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,174.00
Bid: 1,179.00
Ask: 1,184.00
Change: 20.00 (1.73%)
Spread: 5.00 (0.424%)
Open: 1,134.00
High: 1,188.00
Low: 1,134.00
Prev. Close: 1,154.00
FEVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Fevertree revenue grows despite UK, Australia difficulties

Thu, 25th Jan 2024 13:22

(Sharecast News) - Fevertree Drinks reported a 6% improvement in total revenue for 2023 on Thursday, reaching £364.4m.

The AIM-traded firm said of that, UK revenue was down 1% at £114.8m, while US revenue rose 22% to reach £117m.

In Europe, Fevertree's brand revenue inched up 6% to £94.6m, while total revenue reached £105.4 million, growing 4%.

The rest of world segment faced a 14% revenue decline, or 10% at constant currency, although it saw growth when excluding Australia.

Fevertree said its solid performance in the US contributed significantly to overall growth despite currency headwinds and a subdued macroeconomic environment in the fourth quarter.

In the UK, the brand continued to gain market share, with strong trading in the fourth quarter, especially in the on-trade sector.

The off-trade segment also saw notable growth in various product categories.

Europe maintained its premium mixer leadership position despite challenges in consumer sentiment, particularly in Germany.

Regarding the rest of the world, the company said the fall in revenue was mainly due to the transition to a new subsidiary setup in Australia.

However, Fevertree remained the number one premium mixer brand in Australia, and anticipated further growth in the market.

Looking ahead to 2024, Fevertree said it expected to achieve good growth, reaffirming its guidance of 10% revenue growth for the Fevertree brand.

It also anticipated a reduction in portfolio brand revenue in Germany, but expected total group revenue to grow 8%.

The company said it was confident in achieving a significant improvement in gross margin in 2024 through various cost-saving initiatives and sustainable price increases across its markets.

It reiterated its guidance of a 15% adjusted EBITDA margin for 2024.

"The Fevertree brand has performed well in 2023, growing our market share in all of our key markets, despite a challenging macroeconomic environment," said chief executive officer Tim Warrillow.

"The US ended the year as our largest region, where we have extended our leadership position in both the tonic and ginger beer categories.

"The brand enjoyed a strong Christmas trading period in the UK, especially in the on-trade, whilst at home, our new espresso martini mixer clearly became a festive drink of choice."

Warrillow added that despite recession in Germany impacting its European performance and the one-off effect of the transition to its new subsidiary in Australia, the company remained confident of driving good growth in those regions in 2024.

"Importantly, we have driven a significant increase in our EBITDA margin in the second half of the year and are confident that the operational efficiencies we have implemented, alongside a reduction in inflationary cost pressures, will drive a doubling of EBITDA in 2024 and provide a strong platform for profitable growth going forward."

At 1302 GMT, shares in Fevertree Drinks were up 0.49% at 1,017p.

Reporting by Josh White for Sharecast.com.

More News
22 Jul 2022 08:59

RBC Capital downgrades Fever-Tree, slashes price target

(Sharecast News) - RBC Capital Markets downgraded tonic maker Fever-Tree on Friday to 'underperform' from 'sector perform' and slashed the price target to 700p from 1,600p.

Read more
22 Jul 2022 08:12

LONDON BRIEFING: JD Sports backs guidance but UK retail sales weak

(Alliance News) - JD Sports backed annual guidance on a day that brought mixed reports on the UK's wider retail sector.

Read more
21 Jul 2022 09:52

LONDON BROKER RATINGS: Citi likes Haleon, resumes GSK at 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
20 Jul 2022 09:41

LONDON BROKER RATINGS: Goldman likes Haleon but says sell Schroders

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
19 Jul 2022 09:50

LONDON BROKER RATINGS: Fevertree chopped; Berenberg likes Deliveroo

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Jul 2022 08:22

Barclays downgrades Fever-Tree after profit warning

(Sharecast News) - Barclays downgraded tonic maker Fever-Tree on Tuesday to 'equalweight' from 'ovewrweight' following its third profit warning in six months.

Read more
18 Jul 2022 09:52

Jefferies, Deutsche Bank downgrade Fever-Tree

(Sharecast News) - Tonic maker Fever-Tree was downgraded by both Jefferies and Deutsche Bank on Monday following a profit warning last week.

Read more
18 Jul 2022 09:46

LONDON BROKER RATINGS: Trio of downgrades for Fevertree; Admiral cut

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
18 Jul 2022 08:56

LONDON MARKET OPEN: Insurers fall; Euromoney surges as backs takeover

(Alliance News) - Stocks in Europe kicked off the new week on the front foot as expectations of a chunky 100 basis point rate hike from the US Federal Reserve ebbed, with markets now largely pricing in a 75 basis point increase.

Read more
18 Jul 2022 08:10

LONDON BRIEFING: Direct Line adds to warnings from UK motor insurers

(Alliance News) - Direct Line Insurance on Monday cautioned on "heightened volatility across the UK motor insurance market", adding another warning from London-listed insurers.

Read more
15 Jul 2022 22:14

DIRECTOR DEALINGS: Fevertree CEO buys shares worth GBP1 million

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Friday and not separately reported by Alliance News:

Read more
15 Jul 2022 17:13

LONDON MARKET CLOSE: Stocks higher as US rate hikes fears calm

(Alliance News) - Stocks in London ended the week in the green after positive retail sales data from the US, easing fears over future US interest rate hikes.

Read more
15 Jul 2022 14:08

Director dealings: Fevertree CEO spends £1m after disappointing update

(Sharecast News) - Fevertree Drinks was at the top of the list of director buys on Friday, after its co-founder and chief executive splashed on over £1m of shares.

Read more
15 Jul 2022 12:26

LONDON MARKET MIDDAY: Aston Martin jumps on backing from Saudi fund

(Alliance News) - Stocks in London were broadly higher at midday on Friday, amid easing fears over future US interest rate hikes, while the AIM market was weighed down by a lowered earnings guidance from highly rated Fevertree Drinks.

Read more
15 Jul 2022 11:21

AIM WINNERS & LOSERS: Fevertree lowers guidance; DP Poland sales rise

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.